EastWest Bioscience Inc. (TSXV:EAST) announced a non-brokered private placement of up to 2,000,000 common shares at an issue price of CAD 0.05 per share for gross proceeds of up to CAD 100,000 on June 18, 2020. All securities issued in the transaction have a hold period of 4 months. The transaction is subject to approval from TSX Venture Exchange. On June 24, 2020, the company announced TSX Venture Exchange has accepted for filing documentation for 1,992,727 shares. The transaction will include participation from one placee.